Scientists have calculated exactly how water behaves - how the water molecule moves and what its precise geometry is - on a microscopic scale and more accurately than ever before.

Dr Joe Shaw, the managing director and CEO of Sydney-based biosensor specialist Ambri (ASX: ABI), has resigned from the company and will return to the US. [ + ]

Melbourne company Prana Biotechnology has announced an agreement with Neurosciences Victoria and German pharma Schering worth up to $AUD7.5 million over the next three to five years. [ + ]

Accurately predicting the outcomes of spinal surgery is the aim of a $750,000 joint research venture headed by QUT and the Mater Hospital.

Accurately predicting the outcomes of spinal surgery is the aim of a $750,000 joint research venture headed by QUT and the Mater Hospital.

The search for a vaccine against juvenile Type-1 diabetes has received a boost with the establishment of a vaccine development centre at the University of Melbourne.

One of Perth-based probiotics company VRI Biomedical's largest shareholders has launched a bid to remove most of the company's board and move key management to Sydney. [ + ]

For decades, Intel has struggled to build processors that could compete with specialised chips from supercomputing rivals. Today's chips, however, are cheaper, more scalable and fast enough that they're winning over life sciences researchers -- and redefining the rules of supercomputing. [ + ]

Biotech companies are shouldering their way into the first wave of successful applicants to the Federal Government’s re-launched R&D Start grant program, supporting research efforts with commercial potential. [ + ]

Drug firm Bristol-Myers Squibb has listed its Melbourne R&D facility at Noble Park as one of 14 global hubs for clinical research and development. The only other hub in the region is Singapore, with others in the US, Europe and Latin America. [ + ]

As the final step in a process of transformation that has taken almost a year, Victorian gene discovery company Autogen (ASX: AGT) has rebadged itself as AGT Biosciences. [ + ]

A battle for the hearts and minds of Biota Holdings shareholders is intensifying on the eve of a confrontation between the board of the embattled biotech and its largest stakeholder. [ + ]

CSIRO's gene analysis capability has just been given a massive fillip with the opening of the new CSIRO Bioinformatics Facility (CBF) in Canberra. [ + ]

CSIRO Bioinformatics, a spin-off company from CSIRO Mathematical and Information Sciences, has developed new statistical methods it says could lead to improved diagnosis and treatment of cancers. [ + ]

Brisbane biotech Promics is feeling optimistic after successfully concluding human toxicity and safety trials on its anti-inflammatory drug PMX 53. [ + ]